Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023827
Filing Date
2020-11-13
Accepted
2020-11-13 16:02:22
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20200930_10q.htm 10-Q 847860
2 EXHIBIT 31.1 ex_210634.htm EX-31.1 14130
3 EXHIBIT 31.2 ex_210635.htm EX-31.2 14069
4 EXHIBIT 32.1 ex_210636.htm EX-32.1 7930
11 plxp20200930_10qimg001.jpg GRAPHIC 2697
12 plxp20200930_10qimg002.gif GRAPHIC 3623
  Complete submission text file 0001437749-20-023827.txt   3925218

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20200930.xml EX-101.INS 651931
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20200930.xsd EX-101.SCH 33687
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20200930_cal.xml EX-101.CAL 33504
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20200930_def.xml EX-101.DEF 286389
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20200930_lab.xml EX-101.LAB 275767
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20200930_pre.xml EX-101.PRE 303034
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 201311391
SIC: 2834 Pharmaceutical Preparations